/**
 * PharmaConnect Global v3 â€” Static Data
 * Agencies, Partners, Market, Rare Disease, Algeria, Email Templates
 */

export const T = {
  accent: '#3B82F6',
  green: '#10B981',
  red: '#EF4444',
  yellow: '#F59E0B',
  purple: '#8B5CF6',
  cyan: '#06B6D4',
  pink: '#EC4899',
  orange: '#F97316',
}

/** Country/region name or code â†’ flag emoji */
export const COUNTRY_FLAGS: Record<string, string> = {
  France: 'ğŸ‡«ğŸ‡·',
  India: 'ğŸ‡®ğŸ‡³',
  Germany: 'ğŸ‡©ğŸ‡ª',
  Jordan: 'ğŸ‡¯ğŸ‡´',
  China: 'ğŸ‡¨ğŸ‡³',
  Spain: 'ğŸ‡ªğŸ‡¸',
  Italy: 'ğŸ‡®ğŸ‡¹',
  US: 'ğŸ‡ºğŸ‡¸',
  EU: 'ğŸ‡ªğŸ‡º',
  CN: 'ğŸ‡¨ğŸ‡³',
  JP: 'ğŸ‡¯ğŸ‡µ',
  IN: 'ğŸ‡®ğŸ‡³',
  'IN/CN': 'ğŸ‡®ğŸ‡³ğŸ‡¨ğŸ‡³',
  Other: 'ğŸŒ',
}

/** Region â†’ flag emoji for filter buttons */
export const REGION_FLAGS: Record<string, string> = {
  Americas: 'ğŸŒ',
  Europe: 'ğŸ‡ªğŸ‡º',
  'Asia-Pacific': 'ğŸŒ',
  MENA: 'ğŸ•Œ',
  Africa: 'ğŸŒ',
  'North America': 'ğŸŒ',
}

export const CHART_COLORS = [
  T.accent,
  T.green,
  T.purple,
  T.yellow,
  T.red,
  T.cyan,
  T.pink,
  T.orange,
  '#6366F1',
  '#14B8A6',
]

export const THEMES = {
  dark: {
    bg: '#060910',
    card: 'rgba(255,255,255,0.022)',
    cardSolid: '#0d1117',
    border: 'rgba(255,255,255,0.06)',
    text: '#fff',
    sub: 'rgba(255,255,255,0.45)',
    dim: 'rgba(255,255,255,0.2)',
    input: 'rgba(255,255,255,0.03)',
    inputBorder: 'rgba(255,255,255,0.08)',
    hover: 'rgba(255,255,255,0.06)',
    navBg: 'rgba(6,9,16,0.95)',
  },
  light: {
    bg: '#f5f7fa',
    card: '#ffffff',
    cardSolid: '#ffffff',
    border: '#e2e8f0',
    text: '#1a202c',
    sub: '#718096',
    dim: '#a0aec0',
    input: '#f7fafc',
    inputBorder: '#e2e8f0',
    hover: '#edf2f7',
    navBg: 'rgba(255,255,255,0.95)',
  },
} as const

export const LANG = {
  en: {
    appName: 'PharmaConnect Global',
    subtitle: 'Global Pharma Intelligence Â· Algeria ğŸ‡©ğŸ‡¿',
    dashboard: 'Dashboard',
    regulatory: 'Regulatory',
    partners: 'Partners',
    market: 'Market Analysis',
    rare: 'Rare Disease',
    portfolio: 'My Portfolio',
    projects: 'Projects',
    dataHub: 'Data Hub',
    aiAssistant: 'AI Assistant',
    tasks: 'Tasks',
    algeria: 'Algeria Analyzer',
    emails: 'Email Templates',
    search: 'Search...',
    darkMode: 'Dark',
    lightMode: 'Light',
    welcome: 'Your command center for global pharmaceutical expansion',
    agencies: 'Regulatory Agencies',
    globalPartners: 'Global Partners',
    rarePrograms: 'Rare Disease Programs',
    marketCats: 'Market Categories',
    stepByStep: 'Step-by-Step Guide',
    documents: 'Required Documents',
    proTips: 'Pro Tips & Strategy',
    tipsForAlgeria: 'Tips for Algerian Companies',
    addDrug: '+ Add Drug',
    analyze: 'Analyze',
    remove: 'Remove',
    newProject: '+ New Project',
    addAction: '+ Add Action',
    addMeeting: '+ Add Meeting',
    overdue: 'Overdue',
    upcoming: 'Upcoming',
    completed: 'Completed',
    progress: 'Progress',
    send: 'Send',
    save: 'Save',
    cancel: 'Cancel',
    back: 'â† Back',
    teamMembers: 'Team Members',
    notes: 'Notes',
    history: 'History',
    timeline: 'Timeline',
    meetings: 'Meetings',
    overview: 'Overview',
    alerts: 'Alerts',
    notifications: 'Notifications',
    fetchFDA: 'Fetch from openFDA',
    fetchEMA: 'Fetch from EMA',
    fetchingData: 'Fetching...',
    dataSourceFDA: 'FDA (US)',
    dataSourceEMA: 'EMA (EU)',
    liveData: 'Live Data',
    askAI: 'Ask your AI pharma advisor...',
    aiThinking: 'Thinking...',
    algeriaMarket: 'Algerian Pharma Market',
    importData: 'Import Trends',
    localProduction: 'Local Production',
    emailSubject: 'Subject',
    emailTo: 'To',
    emailBody: 'Body',
    useTemplate: 'Use Template',
    uploadDoc: 'Upload Document',
    dragDrop: 'Drag & drop files here',
    ganttChart: 'Project Timeline',
    budgetTracker: 'Budget',
    riskMatrix: 'Risk Matrix',
    newTaskPlaceholder: 'New task...',
    priorityHigh: 'ğŸ”´ High',
    priorityMedium: 'ğŸŸ¡ Medium',
    priorityLow: 'ğŸŸ¢ Low',
    addBtn: '+ Add',
    filterAll: 'All',
    filterActive: 'Active',
    filterDone: 'Done',
    taskManagerDesc: 'Personal task manager',
    products: 'Products',
    contacts: 'Contacts',
    bdStrategy: 'BD Strategy',
    keyProducts: 'Key Products',
    bestApproach: 'Best Approach',
    actionPlan: 'Action Plan',
    brandName: 'Brand Name',
    genericInn: 'Generic / INN',
    therapeuticArea: 'Therapeutic Area',
    selectPlaceholder: 'Select...',
    indication: 'Indication',
    stage: 'Stage',
    type: 'Type',
    gmpCertified: 'GMP Certified',
    whoPrequalified: 'WHO Prequalified',
    globalSize: 'Global Size',
    growth: 'Growth',
    entryDifficulty: 'Entry Difficulty',
    marketAnalysisFor: 'Market Analysis for',
    yourProduct: 'your product',
    matchingPartners: 'Matching Partners',
    recommendedMarkets: 'Recommended Markets',
    footerDisclaimer: 'PharmaConnect Global v3 Â· Feb 2026 Â· Not legal/medical advice',
    footerHub: 'ğŸ‡©ğŸ‡¿ Algeria Pharma Intelligence Hub',
    marketSizeLabel: 'Market Size',
    populationLabel: 'Population',
    importsLabel: 'Imports',
    marketSizeTrend: 'Market Size Trend',
    importSources: 'Import Sources',
    keyLocalPlayers: 'Key Local Players',
    topOpportunities: 'Top Opportunities',
    regulatoryEnv: 'Regulatory Environment',
    stepByStepGuides: 'Step-by-step FDA, EMA, SFDA, JFDA guides',
    partnersDesc: '15+ global pharma companies + MENA',
    marketDesc: 'Global & Algerian market intelligence',
    aiDesc: 'AI advisor for pharma strategy',
    portfolioDesc: 'Enter your drugs & find opportunities',
    projectsDesc: 'Track projects A to Z',
    dataHubDesc: 'Live openFDA data & web scraping',
    algeriaDesc: 'Algerian market deep analysis',
    revenue: 'Revenue',
    details: 'Details',
    contactsCount: 'contacts',
    emailsDesc: 'Professional email templates for pharma BD',
    dataHubSearchError: 'Enter a company or drug name to search',
    dataHubNoResults: 'No results found. Try a different search term (e.g. Pfizer, Johnson).',
    aiConnectionError: 'Connection error. Please try again.',
  },
  fr: {
    appName: 'PharmaConnect Global',
    subtitle: 'Intelligence Pharma Mondiale Â· AlgÃ©rie ğŸ‡©ğŸ‡¿',
    dashboard: 'Tableau de bord',
    regulatory: 'RÃ©glementaire',
    partners: 'Partenaires',
    market: 'Analyse MarchÃ©',
    rare: 'Maladies Rares',
    portfolio: 'Mon Portefeuille',
    projects: 'Projets',
    dataHub: 'Hub DonnÃ©es',
    aiAssistant: 'Assistant IA',
    tasks: 'TÃ¢ches',
    algeria: 'Analyseur AlgÃ©rie',
    emails: 'ModÃ¨les Email',
    search: 'Rechercher...',
    darkMode: 'Sombre',
    lightMode: 'Clair',
    welcome: "Votre centre de commande pour l'expansion pharmaceutique mondiale",
    agencies: 'Agences RÃ©glementaires',
    globalPartners: 'Partenaires Mondiaux',
    rarePrograms: 'Programmes Maladies Rares',
    proTips: 'Conseils & StratÃ©gie',
    tipsForAlgeria: 'Conseils pour les Entreprises AlgÃ©riennes',
    addDrug: '+ Ajouter MÃ©dicament',
    analyze: 'Analyser',
    remove: 'Supprimer',
    newProject: '+ Nouveau Projet',
    addAction: '+ Ajouter Action',
    addMeeting: '+ Ajouter RÃ©union',
    overdue: 'En retard',
    upcoming: 'Ã€ venir',
    completed: 'TerminÃ©',
    progress: 'ProgrÃ¨s',
    send: 'Envoyer',
    save: 'Sauvegarder',
    cancel: 'Annuler',
    back: 'â† Retour',
    teamMembers: "Membres de l'Ã‰quipe",
    notes: 'Notes',
    history: 'Historique',
    timeline: 'Chronologie',
    meetings: 'RÃ©unions',
    overview: "Vue d'ensemble",
    alerts: 'Alertes',
    notifications: 'Notifications',
    fetchFDA: 'RÃ©cupÃ©rer depuis openFDA',
    fetchEMA: 'RÃ©cupÃ©rer depuis EMA',
    fetchingData: 'Chargement...',
    dataSourceFDA: 'FDA (US)',
    dataSourceEMA: 'EMA (EU)',
    liveData: 'DonnÃ©es en Direct',
    askAI: "Posez votre question Ã  l'assistant IA...",
    aiThinking: 'RÃ©flexion...',
    algeriaMarket: 'MarchÃ© Pharma AlgÃ©rien',
    importData: 'Tendances Import',
    localProduction: 'Production Locale',
    emailSubject: 'Objet',
    emailTo: 'Ã€',
    emailBody: 'Corps',
    useTemplate: 'Utiliser ModÃ¨le',
    uploadDoc: 'TÃ©lÃ©charger Document',
    dragDrop: 'Glisser-dÃ©poser les fichiers ici',
    ganttChart: 'Chronologie Projet',
    budgetTracker: 'Budget',
    riskMatrix: 'Matrice de Risques',
    stepByStep: 'Guide Ã‰tape par Ã‰tape',
    documents: 'Documents Requis',
    marketCats: 'CatÃ©gories de MarchÃ©',
    newTaskPlaceholder: 'Nouvelle tÃ¢che...',
    priorityHigh: 'ğŸ”´ Ã‰levÃ©',
    priorityMedium: 'ğŸŸ¡ Moyen',
    priorityLow: 'ğŸŸ¢ Bas',
    addBtn: '+ Ajouter',
    filterAll: 'Tout',
    filterActive: 'Actif',
    filterDone: 'TerminÃ©',
    taskManagerDesc: 'Gestionnaire de tÃ¢ches personnel',
    products: 'Produits',
    contacts: 'Contacts',
    bdStrategy: 'StratÃ©gie BD',
    keyProducts: 'Produits ClÃ©s',
    bestApproach: 'Meilleure Approche',
    actionPlan: "Plan d'Action",
    brandName: 'Nom Commercial',
    genericInn: 'GÃ©nÃ©rique / DCI',
    therapeuticArea: 'Domaine ThÃ©rapeutique',
    selectPlaceholder: 'SÃ©lectionner...',
    indication: 'Indication',
    stage: 'Ã‰tape',
    type: 'Type',
    gmpCertified: 'CertifiÃ© GMP',
    whoPrequalified: 'PrÃ©qualifiÃ© OMS',
    globalSize: 'Taille Mondiale',
    growth: 'Croissance',
    entryDifficulty: 'DifficultÃ© d\'AccÃ¨s',
    marketAnalysisFor: 'Analyse MarchÃ© pour',
    yourProduct: 'votre produit',
    matchingPartners: 'Partenaires Correspondants',
    recommendedMarkets: 'MarchÃ©s RecommandÃ©s',
    footerDisclaimer: 'PharmaConnect Global v3 Â· FÃ©v 2026 Â· Pas de conseil juridique/mÃ©dical',
    footerHub: 'ğŸ‡©ğŸ‡¿ Hub Intelligence Pharma AlgÃ©rie',
    marketSizeLabel: 'Taille MarchÃ©',
    populationLabel: 'Population',
    importsLabel: 'Importations',
    marketSizeTrend: 'Tendance Taille MarchÃ©',
    importSources: 'Sources d\'Import',
    keyLocalPlayers: 'Acteurs Locaux ClÃ©s',
    topOpportunities: 'Meilleures OpportunitÃ©s',
    regulatoryEnv: 'Environnement RÃ©glementaire',
    stepByStepGuides: 'Guides Ã©tape par Ã©tape FDA, EMA, SFDA, JFDA',
    partnersDesc: '15+ sociÃ©tÃ©s pharma mondiales + MENA',
    marketDesc: 'Intelligence marchÃ© mondial & algÃ©rien',
    aiDesc: 'Conseiller IA pour stratÃ©gie pharma',
    portfolioDesc: 'Entrez vos mÃ©dicaments et trouvez des opportunitÃ©s',
    projectsDesc: 'Suivi des projets de A Ã  Z',
    dataHubDesc: 'DonnÃ©es openFDA live et scraping web',
    algeriaDesc: 'Analyse approfondie du marchÃ© algÃ©rien',
    revenue: 'Revenus',
    details: 'DÃ©tails',
    contactsCount: 'contacts',
    emailsDesc: 'ModÃ¨les email professionnels pour BD pharma',
    dataHubSearchError: 'Entrez un nom d\'entreprise ou de mÃ©dicament',
    dataHubNoResults: 'Aucun rÃ©sultat. Essayez un autre terme (ex. Pfizer, Johnson).',
    aiConnectionError: 'Erreur de connexion. RÃ©essayez.',
  },
  ar: {
    appName: 'ÙØ§Ø±Ù…Ø§ ÙƒÙˆÙ†ÙƒØª Ø§Ù„Ø¹Ø§Ù„Ù…ÙŠØ©',
    subtitle: 'Ø§Ù„Ø°ÙƒØ§Ø¡ Ø§Ù„ØµÙŠØ¯Ù„Ø§Ù†ÙŠ Ø§Ù„Ø¹Ø§Ù„Ù…ÙŠ Â· Ø§Ù„Ø¬Ø²Ø§Ø¦Ø± ğŸ‡©ğŸ‡¿',
    dashboard: 'Ù„ÙˆØ­Ø© Ø§Ù„Ù‚ÙŠØ§Ø¯Ø©',
    regulatory: 'Ø§Ù„ØªÙ†Ø¸ÙŠÙ…ÙŠØ©',
    partners: 'Ø§Ù„Ø´Ø±ÙƒØ§Ø¡',
    market: 'ØªØ­Ù„ÙŠÙ„ Ø§Ù„Ø³ÙˆÙ‚',
    rare: 'Ø§Ù„Ø£Ù…Ø±Ø§Ø¶ Ø§Ù„Ù†Ø§Ø¯Ø±Ø©',
    portfolio: 'Ù…Ø­ÙØ¸ØªÙŠ',
    projects: 'Ø§Ù„Ù…Ø´Ø§Ø±ÙŠØ¹',
    dataHub: 'Ù…Ø±ÙƒØ² Ø§Ù„Ø¨ÙŠØ§Ù†Ø§Øª',
    aiAssistant: 'Ø§Ù„Ù…Ø³Ø§Ø¹Ø¯ Ø§Ù„Ø°ÙƒÙŠ',
    tasks: 'Ø§Ù„Ù…Ù‡Ø§Ù…',
    algeria: 'Ù…Ø­Ù„Ù„ Ø§Ù„Ø¬Ø²Ø§Ø¦Ø±',
    emails: 'Ù‚ÙˆØ§Ù„Ø¨ Ø§Ù„Ø¨Ø±ÙŠØ¯',
    search: 'Ø¨Ø­Ø«...',
    darkMode: 'Ø¯Ø§ÙƒÙ†',
    lightMode: 'ÙØ§ØªØ­',
    welcome: 'Ù…Ø±ÙƒØ² Ø§Ù„Ù‚ÙŠØ§Ø¯Ø© Ø§Ù„Ø®Ø§Øµ Ø¨Ùƒ Ù„Ù„ØªÙˆØ³Ø¹ Ø§Ù„ØµÙŠØ¯Ù„Ø§Ù†ÙŠ Ø§Ù„Ø¹Ø§Ù„Ù…ÙŠ',
    agencies: 'Ø§Ù„ÙˆÙƒØ§Ù„Ø§Øª Ø§Ù„ØªÙ†Ø¸ÙŠÙ…ÙŠØ©',
    globalPartners: 'Ø§Ù„Ø´Ø±ÙƒØ§Ø¡ Ø§Ù„Ø¹Ø§Ù„Ù…ÙŠÙˆÙ†',
    rarePrograms: 'Ø¨Ø±Ø§Ù…Ø¬ Ø§Ù„Ø£Ù…Ø±Ø§Ø¶ Ø§Ù„Ù†Ø§Ø¯Ø±Ø©',
    proTips: 'Ù†ØµØ§Ø¦Ø­ ÙˆØ§Ø³ØªØ±Ø§ØªÙŠØ¬ÙŠØ§Øª',
    tipsForAlgeria: 'Ù†ØµØ§Ø¦Ø­ Ù„Ù„Ø´Ø±ÙƒØ§Øª Ø§Ù„Ø¬Ø²Ø§Ø¦Ø±ÙŠØ©',
    addDrug: '+ Ø¥Ø¶Ø§ÙØ© Ø¯ÙˆØ§Ø¡',
    analyze: 'ØªØ­Ù„ÙŠÙ„',
    remove: 'Ø­Ø°Ù',
    newProject: '+ Ù…Ø´Ø±ÙˆØ¹ Ø¬Ø¯ÙŠØ¯',
    addAction: '+ Ø¥Ø¶Ø§ÙØ© Ø¥Ø¬Ø±Ø§Ø¡',
    addMeeting: '+ Ø¥Ø¶Ø§ÙØ© Ø§Ø¬ØªÙ…Ø§Ø¹',
    overdue: 'Ù…ØªØ£Ø®Ø±',
    upcoming: 'Ù‚Ø§Ø¯Ù…',
    completed: 'Ù…ÙƒØªÙ…Ù„',
    progress: 'Ø§Ù„ØªÙ‚Ø¯Ù…',
    send: 'Ø¥Ø±Ø³Ø§Ù„',
    save: 'Ø­ÙØ¸',
    cancel: 'Ø¥Ù„ØºØ§Ø¡',
    back: 'â†’ Ø±Ø¬ÙˆØ¹',
    teamMembers: 'Ø£Ø¹Ø¶Ø§Ø¡ Ø§Ù„ÙØ±ÙŠÙ‚',
    notes: 'Ù…Ù„Ø§Ø­Ø¸Ø§Øª',
    history: 'Ø§Ù„Ø³Ø¬Ù„',
    timeline: 'Ø§Ù„Ø¬Ø¯ÙˆÙ„ Ø§Ù„Ø²Ù…Ù†ÙŠ',
    meetings: 'Ø§Ù„Ø§Ø¬ØªÙ…Ø§Ø¹Ø§Øª',
    overview: 'Ù†Ø¸Ø±Ø© Ø¹Ø§Ù…Ø©',
    alerts: 'Ø§Ù„ØªÙ†Ø¨ÙŠÙ‡Ø§Øª',
    notifications: 'Ø§Ù„Ø¥Ø´Ø¹Ø§Ø±Ø§Øª',
    fetchFDA: 'Ø¬Ù„Ø¨ Ù…Ù† openFDA',
    fetchEMA: 'Ø¬Ù„Ø¨ Ù…Ù† EMA',
    fetchingData: 'Ø¬Ø§Ø±ÙŠ Ø§Ù„ØªØ­Ù…ÙŠÙ„...',
    dataSourceFDA: 'FDA (Ø§Ù„ÙˆÙ„Ø§ÙŠØ§Øª Ø§Ù„Ù…ØªØ­Ø¯Ø©)',
    dataSourceEMA: 'EMA (Ø§Ù„Ø§ØªØ­Ø§Ø¯ Ø§Ù„Ø£ÙˆØ±ÙˆØ¨ÙŠ)',
    liveData: 'Ø¨ÙŠØ§Ù†Ø§Øª Ù…Ø¨Ø§Ø´Ø±Ø©',
    askAI: 'Ø§Ø³Ø£Ù„ Ù…Ø³ØªØ´Ø§Ø±Ùƒ Ø§Ù„Ø°ÙƒÙŠ...',
    aiThinking: 'Ø¬Ø§Ø±ÙŠ Ø§Ù„ØªÙÙƒÙŠØ±...',
    algeriaMarket: 'Ø³ÙˆÙ‚ Ø§Ù„Ø£Ø¯ÙˆÙŠØ© Ø§Ù„Ø¬Ø²Ø§Ø¦Ø±ÙŠ',
    importData: 'Ø§ØªØ¬Ø§Ù‡Ø§Øª Ø§Ù„Ø§Ø³ØªÙŠØ±Ø§Ø¯',
    localProduction: 'Ø§Ù„Ø¥Ù†ØªØ§Ø¬ Ø§Ù„Ù…Ø­Ù„ÙŠ',
    emailSubject: 'Ø§Ù„Ù…ÙˆØ¶ÙˆØ¹',
    emailTo: 'Ø¥Ù„Ù‰',
    emailBody: 'Ø§Ù„Ù†Øµ',
    useTemplate: 'Ø§Ø³ØªØ®Ø¯Ø§Ù… Ù‚Ø§Ù„Ø¨',
    uploadDoc: 'Ø±ÙØ¹ Ù…Ø³ØªÙ†Ø¯',
    dragDrop: 'Ø§Ø³Ø­Ø¨ Ø§Ù„Ù…Ù„ÙØ§Øª Ù‡Ù†Ø§',
    ganttChart: 'Ø§Ù„Ø¬Ø¯ÙˆÙ„ Ø§Ù„Ø²Ù…Ù†ÙŠ Ù„Ù„Ù…Ø´Ø±ÙˆØ¹',
    budgetTracker: 'Ø§Ù„Ù…ÙŠØ²Ø§Ù†ÙŠØ©',
    riskMatrix: 'Ù…ØµÙÙˆÙØ© Ø§Ù„Ù…Ø®Ø§Ø·Ø±',
    stepByStep: 'Ø¯Ù„ÙŠÙ„ Ø®Ø·ÙˆØ© Ø¨Ø®Ø·ÙˆØ©',
    documents: 'Ø§Ù„Ù…Ø³ØªÙ†Ø¯Ø§Øª Ø§Ù„Ù…Ø·Ù„ÙˆØ¨Ø©',
    marketCats: 'ÙØ¦Ø§Øª Ø§Ù„Ø³ÙˆÙ‚',
    newTaskPlaceholder: 'Ù…Ù‡Ù…Ø© Ø¬Ø¯ÙŠØ¯Ø©...',
    priorityHigh: 'ğŸ”´ Ø¹Ø§Ù„ÙŠ',
    priorityMedium: 'ğŸŸ¡ Ù…ØªÙˆØ³Ø·',
    priorityLow: 'ğŸŸ¢ Ù…Ù†Ø®ÙØ¶',
    addBtn: '+ Ø¥Ø¶Ø§ÙØ©',
    filterAll: 'Ø§Ù„ÙƒÙ„',
    filterActive: 'Ù†Ø´Ø·',
    filterDone: 'Ù…ÙƒØªÙ…Ù„',
    taskManagerDesc: 'Ù…Ø¯ÙŠØ± Ø§Ù„Ù…Ù‡Ø§Ù… Ø§Ù„Ø´Ø®ØµÙŠ',
    products: 'Ø§Ù„Ù…Ù†ØªØ¬Ø§Øª',
    contacts: 'Ø¬Ù‡Ø§Øª Ø§Ù„Ø§ØªØµØ§Ù„',
    bdStrategy: 'Ø§Ø³ØªØ±Ø§ØªÙŠØ¬ÙŠØ© BD',
    keyProducts: 'Ø§Ù„Ù…Ù†ØªØ¬Ø§Øª Ø§Ù„Ø±Ø¦ÙŠØ³ÙŠØ©',
    bestApproach: 'Ø£ÙØ¶Ù„ Ù†Ù‡Ø¬',
    actionPlan: 'Ø®Ø·Ø© Ø§Ù„Ø¹Ù…Ù„',
    brandName: 'Ø§Ù„Ø§Ø³Ù… Ø§Ù„ØªØ¬Ø§Ø±ÙŠ',
    genericInn: 'Ø§Ù„Ø¹Ø§Ù… / Ø§Ù„Ø¯ÙˆØ§Ø¡ Ø§Ù„Ø£Ø³Ø§Ø³ÙŠ',
    therapeuticArea: 'Ø§Ù„Ù…Ø¬Ø§Ù„ Ø§Ù„Ø¹Ù„Ø§Ø¬ÙŠ',
    selectPlaceholder: 'Ø§Ø®ØªØ±...',
    indication: 'Ø§Ù„Ø¯ÙˆØ§Ø¹ÙŠ',
    stage: 'Ø§Ù„Ù…Ø±Ø­Ù„Ø©',
    type: 'Ø§Ù„Ù†ÙˆØ¹',
    gmpCertified: 'Ù…Ø¹ØªÙ…Ø¯ GMP',
    whoPrequalified: 'Ù…Ø¹ØªÙ…Ø¯ Ù…Ø³Ø¨Ù‚Ø§Ù‹ Ù…Ù† Ù…Ù†Ø¸Ù…Ø© Ø§Ù„ØµØ­Ø© Ø§Ù„Ø¹Ø§Ù„Ù…ÙŠØ©',
    globalSize: 'Ø§Ù„Ø­Ø¬Ù… Ø§Ù„Ø¹Ø§Ù„Ù…ÙŠ',
    growth: 'Ø§Ù„Ù†Ù…Ùˆ',
    entryDifficulty: 'ØµØ¹ÙˆØ¨Ø© Ø§Ù„Ø¯Ø®ÙˆÙ„',
    marketAnalysisFor: 'ØªØ­Ù„ÙŠÙ„ Ø§Ù„Ø³ÙˆÙ‚ Ù„Ù€',
    yourProduct: 'Ù…Ù†ØªØ¬Ùƒ',
    matchingPartners: 'Ø§Ù„Ø´Ø±ÙƒØ§Ø¡ Ø§Ù„Ù…Ø·Ø§Ø¨Ù‚ÙˆÙ†',
    recommendedMarkets: 'Ø§Ù„Ø£Ø³ÙˆØ§Ù‚ Ø§Ù„Ù…ÙˆØµÙ‰ Ø¨Ù‡Ø§',
    footerDisclaimer: 'PharmaConnect Global v3 Â· Ø´Ø¨Ø§Ø· 2026 Â· Ù„ÙŠØ³Øª Ù…Ø´ÙˆØ±Ø© Ù‚Ø§Ù†ÙˆÙ†ÙŠØ©/Ø·Ø¨ÙŠØ©',
    footerHub: 'ğŸ‡©ğŸ‡¿ Ù…Ø±ÙƒØ² Ø§Ù„Ø°ÙƒØ§Ø¡ Ø§Ù„ØµÙŠØ¯Ù„Ø§Ù†ÙŠ Ø§Ù„Ø¬Ø²Ø§Ø¦Ø±ÙŠ',
    marketSizeLabel: 'Ø­Ø¬Ù… Ø§Ù„Ø³ÙˆÙ‚',
    populationLabel: 'Ø§Ù„Ø³ÙƒØ§Ù†',
    importsLabel: 'Ø§Ù„ÙˆØ§Ø±Ø¯Ø§Øª',
    marketSizeTrend: 'Ø§ØªØ¬Ø§Ù‡ Ø­Ø¬Ù… Ø§Ù„Ø³ÙˆÙ‚',
    importSources: 'Ù…ØµØ§Ø¯Ø± Ø§Ù„Ø§Ø³ØªÙŠØ±Ø§Ø¯',
    keyLocalPlayers: 'Ø§Ù„Ù„Ø§Ø¹Ø¨ÙˆÙ† Ø§Ù„Ù…Ø­Ù„ÙŠÙˆÙ† Ø§Ù„Ø±Ø¦ÙŠØ³ÙŠÙˆÙ†',
    topOpportunities: 'Ø£ÙØ¶Ù„ Ø§Ù„ÙØ±Øµ',
    regulatoryEnv: 'Ø§Ù„Ø¨ÙŠØ¦Ø© Ø§Ù„ØªÙ†Ø¸ÙŠÙ…ÙŠØ©',
    stepByStepGuides: 'Ø¯Ù„ÙŠÙ„ Ø®Ø·ÙˆØ© Ø¨Ø®Ø·ÙˆØ© FDA Ùˆ EMA Ùˆ SFDA Ùˆ JFDA',
    partnersDesc: '15+ Ø´Ø±ÙƒØ© Ø£Ø¯ÙˆÙŠØ© Ø¹Ø§Ù„Ù…ÙŠØ© + MENA',
    marketDesc: 'Ø°ÙƒØ§Ø¡ Ø§Ù„Ø³ÙˆÙ‚ Ø§Ù„Ø¹Ø§Ù„Ù…ÙŠ ÙˆØ§Ù„Ø¬Ø²Ø§Ø¦Ø±ÙŠ',
    aiDesc: 'Ù…Ø³ØªØ´Ø§Ø± Ø§Ù„Ø°ÙƒØ§Ø¡ Ø§Ù„Ø§ØµØ·Ù†Ø§Ø¹ÙŠ Ù„Ø§Ø³ØªØ±Ø§ØªÙŠØ¬ÙŠØ© Ø§Ù„Ø£Ø¯ÙˆÙŠØ©',
    portfolioDesc: 'Ø£Ø¯Ø®Ù„ Ø£Ø¯ÙˆÙŠØªÙƒ ÙˆØ§Ø¹Ø«Ø± Ø¹Ù„Ù‰ Ø§Ù„ÙØ±Øµ',
    projectsDesc: 'ØªØªØ¨Ø¹ Ø§Ù„Ù…Ø´Ø§Ø±ÙŠØ¹ Ù…Ù† A Ø¥Ù„Ù‰ Z',
    dataHubDesc: 'Ø¨ÙŠØ§Ù†Ø§Øª openFDA Ø§Ù„Ù…Ø¨Ø§Ø´Ø±Ø© ÙˆØ¬Ù…Ø¹ Ø§Ù„Ø¨ÙŠØ§Ù†Ø§Øª',
    algeriaDesc: 'ØªØ­Ù„ÙŠÙ„ Ø¹Ù…ÙŠÙ‚ Ù„Ù„Ø³ÙˆÙ‚ Ø§Ù„Ø¬Ø²Ø§Ø¦Ø±ÙŠ',
    revenue: 'Ø§Ù„Ø¥ÙŠØ±Ø§Ø¯Ø§Øª',
    details: 'Ø§Ù„ØªÙØ§ØµÙŠÙ„',
    contactsCount: 'Ø¬Ù‡Ø§Øª Ø§ØªØµØ§Ù„',
    emailsDesc: 'Ù‚ÙˆØ§Ù„Ø¨ Ø¨Ø±ÙŠØ¯ Ø¥Ù„ÙƒØªØ±ÙˆÙ†ÙŠ Ø§Ø­ØªØ±Ø§ÙÙŠØ© Ù„Ù€ BD Ø§Ù„ØµÙŠØ¯Ù„Ø§Ù†ÙŠØ©',
    dataHubSearchError: 'Ø£Ø¯Ø®Ù„ Ø§Ø³Ù… Ø´Ø±ÙƒØ© Ø£Ùˆ Ø¯ÙˆØ§Ø¡ Ù„Ù„Ø¨Ø­Ø«',
    dataHubNoResults: 'Ù„Ù… ÙŠØªÙ… Ø§Ù„Ø¹Ø«ÙˆØ± Ø¹Ù„Ù‰ Ù†ØªØ§Ø¦Ø¬. Ø¬Ø±Ø¨ Ù…ØµØ·Ù„Ø­Ù‹Ø§ Ù…Ø®ØªÙ„ÙÙ‹Ø§ (Ù…Ø«Ù„ PfizerØŒ Johnson).',
    aiConnectionError: 'Ø®Ø·Ø£ ÙÙŠ Ø§Ù„Ø§ØªØµØ§Ù„. ÙŠØ±Ø¬Ù‰ Ø§Ù„Ù…Ø­Ø§ÙˆÙ„Ø© Ù…Ø±Ø© Ø£Ø®Ø±Ù‰.',
  },
} as const

export type LangKey = keyof typeof LANG

export const SC: Record<string, string> = {
  'Top Seller': '#FFD700',
  'Mega Blockbuster': '#FFD700',
  'Rising Star': '#00E676',
  'High Growth': '#00E676',
  'Fast Growing': '#00E676',
  'Strong Growth': '#69F0AE',
  'New Launch': '#448AFF',
  'Pipeline Star': '#E040FB',
  Flagship: '#FFD700',
  Blockbuster: '#FF9100',
  'Patent Cliff': '#FF5252',
  Mature: '#78909C',
  Stable: '#90A4AE',
  Established: '#78909C',
  Growing: '#4FC3F7',
  Emerging: '#4FC3F7',
  'Pfizer $6B Deal': '#FF1744',
}

export { AGENCIES_DATA } from './pharma-global-v3-agencies'
export { PARTNERS_DATA } from './pharma-global-v3-partners'

export const MARKET_CATS = [
  { name: 'Oncology', size: 223, growth: 12, topMarkets: ['US 45%', 'EU 22%', 'CN 12%', 'JP 8%'], hot: ['ADCs', 'Bispecifics', 'CAR-T', 'IO combos'], difficulty: 5, opportunity: 'High unmet need in emerging markets. Biosimilar oncology growing.' },
  { name: 'Immunology', size: 95, growth: 8, topMarkets: ['US 50%', 'EU 25%', 'JP 8%'], hot: ['IL-4/13', 'IL-17', 'JAK inhibitors', 'Oral biologics'], difficulty: 4, opportunity: 'Biosimilars of aging biologics. Novel oral formulations.' },
  { name: 'GLP-1/Obesity', size: 80, growth: 30, topMarkets: ['US 55%', 'EU 20%', 'JP 5%', 'CN 8%'], hot: ['GLP-1 agonists', 'Oral GLP-1', 'Triple agonists'], difficulty: 5, opportunity: 'Massive demand > supply. Manufacturing partnerships. Oral formulations.' },
  { name: 'Vaccines', size: 70, growth: 10, topMarkets: ['US 35%', 'EU 25%', 'CN 15%'], hot: ['mRNA', 'RSV', 'Combo vaccines', 'Pandemic prep'], difficulty: 3, opportunity: 'EXCELLENT for Algeria. WHO PQ opens global procurement. Tech transfer proven.' },
  { name: 'Rare Disease', size: 52, growth: 12, topMarkets: ['US 55%', 'EU 30%', 'JP 8%'], hot: ['Gene therapy', 'ERT', 'ASO/siRNA', 'CRISPR'], difficulty: 4, opportunity: 'High pricing, orphan exclusivity. Growing global focus.' },
  { name: 'Generics & Biosimilars', size: 430, growth: 7, topMarkets: ['US 28%', 'EU 25%', 'IN/CN 20%'], hot: ['Complex generics', 'Biosimilars', '505(b)(2)'], difficulty: 2, opportunity: 'BEST entry for Algeria. Lower R&D. Large global demand. WHO PQ.' },
  { name: 'Anti-infectives', size: 55, growth: 5, topMarkets: ['US 30%', 'EU 20%', 'CN 15%'], hot: ['AMR antibiotics', 'Antifungals', 'Antivirals'], difficulty: 2, opportunity: 'Good for Algeria. AMR is global priority. GARDP partnerships.' },
  { name: 'CNS/Neuroscience', size: 85, growth: 8, topMarkets: ['US 50%', 'EU 25%', 'JP 10%'], hot: ["Alzheimer's", 'Depression', "Parkinson's"], difficulty: 4, opportunity: "Huge unmet need. Many failed trials = opportunity for novel approaches." },
]

export const RARE_DISEASES = [
  { name: 'Spinal Muscular Atrophy', prevalence: '1:10,000', area: 'Neurology', status: 'Active', leads: ['Novartis (Zolgensma)', 'Roche (Evrysdi)', 'Biogen'], approach: 'Gene therapy, SMN enhancement', opportunity: 'Gene therapy manufacturing partnerships' },
  { name: 'Duchenne Muscular Dystrophy', prevalence: '1:5,000 males', area: 'Neurology', status: 'Active', leads: ['Sarepta', 'Solid Bio', 'Pfizer'], approach: 'Gene therapy, exon skipping', opportunity: 'Gene therapy mfg, ASO development' },
  { name: 'Cystic Fibrosis', prevalence: '1:3,500', area: 'Pulmonology', status: 'Breakthrough', leads: ['Vertex (Trikafta)', 'AbbVie'], approach: 'CFTR modulators, gene therapy', opportunity: 'Next-gen CFTR modulators' },
  { name: 'Sickle Cell Disease', prevalence: '1:365 (African descent)', area: 'Hematology', status: 'Gene Therapy Era', leads: ['Vertex/CRISPR (Casgevy)', 'Bluebird Bio'], approach: 'CRISPR gene editing, HbF induction', opportunity: 'HUGE for Africa. Affordable therapies needed.' },
  { name: 'Hemophilia A & B', prevalence: '1:5,000 (A)', area: 'Hematology', status: 'Revolution', leads: ['Roche (Hemlibra)', 'BioMarin', 'Pfizer'], approach: 'Bispecifics, gene therapy', opportunity: 'Gene therapy mfg, subcutaneous factors' },
  { name: 'Gaucher Disease', prevalence: '1:40,000', area: 'Metabolic', status: 'Treated', leads: ['Sanofi (Cerdelga)', 'Takeda'], approach: 'ERT, substrate reduction', opportunity: 'Oral therapies, gene therapy' },
  { name: 'PKU', prevalence: '1:12,000', area: 'Metabolic', status: 'Active', leads: ['BioMarin (Palynziq)'], approach: 'Enzyme substitution, gene therapy', opportunity: 'Gene therapy, dietary products' },
  { name: 'ALS', prevalence: '2:100,000', area: 'Neurology', status: 'Active', leads: ['Biogen/Ionis', 'Amylyx'], approach: 'Antisense, SOD1 targeting', opportunity: 'Novel targets, biomarker development' },
]

export const ALGERIA_DATA = {
  marketSize: '$4.2B',
  growth: '+8.5% CAGR',
  population: '46M+',
  localProduction: '52%',
  imports: '48%',
  topImportSources: [
    { name: 'France', pct: 22, flag: 'ğŸ‡«ğŸ‡·' },
    { name: 'India', pct: 18, flag: 'ğŸ‡®ğŸ‡³' },
    { name: 'Germany', pct: 12, flag: 'ğŸ‡©ğŸ‡ª' },
    { name: 'Jordan', pct: 8, flag: 'ğŸ‡¯ğŸ‡´' },
    { name: 'China', pct: 7, flag: 'ğŸ‡¨ğŸ‡³' },
    { name: 'Spain', pct: 6, flag: 'ğŸ‡ªğŸ‡¸' },
    { name: 'Italy', pct: 5, flag: 'ğŸ‡®ğŸ‡¹' },
    { name: 'Other', pct: 22, flag: 'ğŸŒ' },
  ],
  topCategories: [
    { name: 'Anti-infectives', pct: 18 },
    { name: 'Cardiovascular', pct: 15 },
    { name: 'CNS', pct: 12 },
    { name: 'Diabetes', pct: 11 },
    { name: 'Oncology', pct: 10 },
    { name: 'Respiratory', pct: 8 },
    { name: 'GI', pct: 7 },
    { name: 'Dermatology', pct: 5 },
    { name: 'Other', pct: 14 },
  ],
  yearlyTrend: [
    { yr: '2020', val: 3.1 },
    { yr: '2021', val: 3.4 },
    { yr: '2022', val: 3.6 },
    { yr: '2023', val: 3.8 },
    { yr: '2024', val: 4.0 },
    { yr: '2025', val: 4.2 },
    { yr: '2026P', val: 4.5 },
    { yr: '2027P', val: 4.9 },
  ],
  localVsImport: [
    { yr: '2019', local: 42, imp: 58 },
    { yr: '2020', local: 44, imp: 56 },
    { yr: '2021', local: 46, imp: 54 },
    { yr: '2022', local: 48, imp: 52 },
    { yr: '2023', local: 50, imp: 50 },
    { yr: '2024', local: 52, imp: 48 },
    { yr: '2025P', local: 55, imp: 45 },
  ],
  keyPlayers: ['Saidal Group', 'Biopharm', 'El Kendi', 'Sanofi Algeria', 'Novo Nordisk Algeria', 'Hikma Algeria', 'LPA (Laboratoire Pharmaceutique AlgÃ©rien)'],
  regulations: 'ANPP (Agence Nationale des Produits Pharmaceutiques) regulates. Govt promotes local production (target 70% by 2030). Import substitution policy. Price controls. Mandatory local registration.',
  opportunities: ['Biosimilar manufacturing (govt incentives)', 'Vaccine production (post-COVID priority)', 'Oncology generics (growing demand)', 'Diabetes treatments (high prevalence)', 'Contract manufacturing for Africa', 'Technology transfer partnerships', 'Generic API production'],
}

export const EMAIL_TEMPLATES = [
  {
    id: 'intro',
    name: 'Initial Introduction',
    subject: 'Partnership Inquiry â€” [Your Company] Algeria',
    body: `Dear [Partner Name] Team,

I am writing from [Your Company], a pharmaceutical [manufacturer/laboratory] based in Algeria, to explore potential collaboration opportunities.

We specialize in [your therapeutic areas] and currently have [X products] registered with ANPP (Algerian National Pharmaceutical Agency). Our facility is GMP-certified and we are interested in expanding our international footprint.

We are particularly interested in:
- [Area 1: e.g., licensing agreements for your products in MENA/Africa]
- [Area 2: e.g., technology transfer for manufacturing]
- [Area 3: e.g., joint development of biosimilars]

We would welcome the opportunity to discuss this further at your convenience, or to meet at [upcoming conference/event].

Best regards,
[Your Name]
[Your Title]
[Your Company]
[Phone] | [Email]`,
  },
  {
    id: 'followup',
    name: 'Meeting Follow-up',
    subject: 'Follow-up: Meeting on [Date] â€” [Project Name]',
    body: `Dear [Name],

Thank you for the productive meeting on [Date]. I wanted to summarize the key points discussed and next steps:

Key Discussion Points:
1. [Point 1]
2. [Point 2]
3. [Point 3]

Agreed Next Steps:
- [Action 1] â€” Responsible: [Name] â€” Deadline: [Date]
- [Action 2] â€” Responsible: [Name] â€” Deadline: [Date]
- [Action 3] â€” Responsible: [Name] â€” Deadline: [Date]

Please confirm these action items at your earliest convenience. Our next meeting is scheduled for [Date/Time].

Best regards,
[Your Name]`,
  },
  {
    id: 'nda',
    name: 'NDA / Confidentiality Request',
    subject: 'Confidentiality Agreement â€” [Project Name]',
    body: `Dear [Name],

As discussed, we would like to proceed with formalizing our discussions through a mutual Non-Disclosure Agreement (NDA).

Please find attached our proposed CDA/NDA template. Key terms:
- Mutual confidentiality obligations
- Duration: [X] years
- Governing law: [Jurisdiction]

We are open to using your standard template if preferred. Please review and advise on any amendments needed.

We look forward to progressing our discussions once the NDA is in place.

Best regards,
[Your Name]`,
  },
  {
    id: 'regulatory',
    name: 'Regulatory Inquiry',
    subject: 'Regulatory Inquiry â€” [Product Name] Registration in [Country]',
    body: `Dear [Agency/Contact],

We are writing to inquire about the registration requirements for [Product Name] ([generic name]) in [Country].

Product Details:
- Product: [Brand Name] ([Generic/INN])
- Dosage Form: [e.g., Film-coated tablets, 500mg]
- Therapeutic Area: [e.g., Anti-infectives]
- Currently registered in: [List countries]
- GMP Status: [Certified by whom]

We would appreciate guidance on:
1. Required documentation for registration
2. Current processing timelines
3. Fee schedule
4. Any expedited pathways available

Please advise on the best way to proceed with a formal application.

Best regards,
[Your Name]`,
  },
  {
    id: 'proposal',
    name: 'Business Proposal',
    subject: 'Business Proposal â€” Strategic Partnership for [Region/Product]',
    body: `Dear [Name],

Executive Summary:
[Your Company] proposes a strategic partnership with [Partner] for [describe objective].

Our Capabilities:
- GMP-certified facility in Algeria ([capacity])
- [X] registered products across [Y] therapeutic areas
- Distribution network covering [regions]
- Regulatory expertise in MENA/Africa markets

Proposed Collaboration:
- Model: [Licensing / JV / Distribution / Tech Transfer]
- Products: [List target products]
- Markets: [Target markets]
- Timeline: [Proposed timeline]

Value Proposition:
- Access to Algeria ($4.2B market) and MENA/Africa
- Local manufacturing incentives (Algerian government 2030 plan)
- Competitive manufacturing costs
- Established regulatory relationships

We have prepared a detailed proposal deck and would welcome the opportunity to present it to your BD team.

Best regards,
[Your Name]`,
  },
]
